SOX11 and neuroendocrine neoplasm: Except for MMs, overexpressed SOX11, as an indicator of aggressivity, was reported in mantle cell lymphoma [29,30], basal-like breast cancer [31], solid pseudopapillary neoplasm of the pancreas [17,32], and neuroendocrine tumors of the lung [33].